Takanori Utsumi

发表

Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19

J. Casanova, O. Ohara, H. Kanegane, 2022, Journal of Clinical Immunology.

Neutralizing Type I Interferon Autoantibodies in Japanese Patients With Severe COVID-19

J. Casanova, H. Kanegane, T. Morio, 2022, Research square.

Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases

H. Kanegane, S. Okada, M. Tsumura, 2022, Journal of Clinical Immunology.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

A Case with Spondyloenchondrodysplasia Treated with Growth Hormone

S. Okada, Masao Kobayashi, G. Nishimura, 2017, Front. Endocrinol..

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Mark S. Anderson, P. Gregersen, R. Nussbaum, 2021, Science Immunology.

Inborn errors of immunity with loss- and gain-of-function germline mutations in STAT1.

S. Okada, S. Karakawa, Takaki Asano, 2022, Clinical and experimental immunology.

Exclusive Characteristics of the p.E555K Dominant-Negative Variant in Autosomal Dominant E47 Deficiency

B. Boisson, M. Tsumura, D. Bogunovic, 2024, Journal of clinical immunology.